These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 18510578)
1. Analysis of enzyme-treated red blood cell surface and haemagglutination using a theory of soft-particle electrophoresis. Hyono A; Mazda T; Okazaki H; Tadokoro K; Ohshima H Vox Sang; 2008 Aug; 95(2):131-6. PubMed ID: 18510578 [TBL] [Abstract][Full Text] [Related]
2. Hemagglutination and the closest distance of approach of normal, neuraminidase- and papain-treated erythrocytes. van Oss CJ; Absolom DR Vox Sang; 1984; 47(3):250-6. PubMed ID: 6431697 [TBL] [Abstract][Full Text] [Related]
3. Impacts of papain and neuraminidase enzyme treatment on electrohydrodynamics and IgG-mediated agglutination of type A red blood cells. Hyono A; Gaboriaud F; Mazda T; Takata Y; Ohshima H; Duval JF Langmuir; 2009 Sep; 25(18):10873-85. PubMed ID: 19735140 [TBL] [Abstract][Full Text] [Related]
4. Effects of proteases and neuraminidase on RBC surface charge and agglutination. A kinetic study. Luner SJ; Sturgeon P; Szklarek D; McQuiston DT Vox Sang; 1975; 28(3):184-99. PubMed ID: 164087 [TBL] [Abstract][Full Text] [Related]
5. Critical review of protease-treated red cell tests for the detection of irregular blood group antibodies during pregnancy. Jemmolo G; Malferrari F; Tazzari PL; Conte R Vox Sang; 1995; 69(2):144. PubMed ID: 8585199 [No Abstract] [Full Text] [Related]
6. Autoradiographic estimation of red cell D antigen content using 125I-anti-D and 125I membrane labeling. Rearden A; Masouredis SP Blood; 1977 Dec; 50(6):971-9. PubMed ID: 411528 [No Abstract] [Full Text] [Related]
7. On the agglutinogens of red cells developed with proteolytic enzymes and neuraminidase. Sagisaka K; Takahashi K Tohoku J Exp Med; 1976 Oct; 120(2):169-75. PubMed ID: 982434 [TBL] [Abstract][Full Text] [Related]
8. The antiglobulin reaction with native and enzyme-modified red cells. Rearden A; Masouredis SP Transfusion; 1980; 20(4):377-83. PubMed ID: 6773190 [TBL] [Abstract][Full Text] [Related]
9. Quantitative haemagglutination. 4. Effect of neuraminidase treatment on agglutination by blood group antibodies. Greenwalt TJ; Steane EA Br J Haematol; 1973 Aug; 25(2):207-15. PubMed ID: 4199348 [No Abstract] [Full Text] [Related]
10. Agglutination of red blood cells by polyelectrolytes and antibodies. Danon D Bibl Anat; 1973; 11():289-95. PubMed ID: 4207766 [No Abstract] [Full Text] [Related]
11. Cold agglutinin activity is common among human monoclonal IgM Rh system antibodies using the V4-34 heavy chain variable gene segment. Thorpe SJ; Boult CE; Stevenson FK; Scott ML; Sutherland J; Spellerberg MB; Natvig JB; Thompson KM Transfusion; 1997; 37(11-12):1111-6. PubMed ID: 9426632 [TBL] [Abstract][Full Text] [Related]
12. Electrophoretic mobility of a "soft particle" with a nonuniformly charged surface layer as a model for cells. Ohshima H; Kondo T Biophys Chem; 1993 Apr; 46(2):145-52. PubMed ID: 8513115 [TBL] [Abstract][Full Text] [Related]
16. Characterization of the T antigen and T agglutinin in inbred rats. Noeman SA; Misra DN; Gill TJ Immunology; 1980 Feb; 39(2):219-29. PubMed ID: 6155326 [TBL] [Abstract][Full Text] [Related]
17. Effect of papain on the interaction between human monocytes, erythrocytes, and IgG. Kenna MA; Cooper RA; Schrieber AD Blood; 1975 Aug; 46(2):245-52. PubMed ID: 806312 [TBL] [Abstract][Full Text] [Related]
18. Rh0(D) activity of red blood cells and stroma treated with proteolytic enzymes. Yokoi T; Iwasa M; Sagisaka K Tohoku J Exp Med; 1984 May; 143(1):99-105. PubMed ID: 6431638 [TBL] [Abstract][Full Text] [Related]
19. INHIBITION OF AN ANTI-D BY A NORMAL SERUM FACTOR. FREIESLEBEN E; JENSEN KG Vox Sang; 1964; 9():65-9. PubMed ID: 14115409 [No Abstract] [Full Text] [Related]
20. Anti-D prozone and membrane sulfhydryl modification. Jameson JT; Kleeman JE; Masouredis SP; Victoria EJ Transfusion; 1984; 24(2):130-5. PubMed ID: 6324423 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]